Webinar | October 7, 2020

Quality And Compliance In Times Of Crisis

Already in 2020, the FDA has issued in excess of 50 warning letters to organizations that are COVID-19 related. How will this impact the approach to validated systems in the future and what bearing will it have on the risk-based approach that the regulatory authorities have been taking to Quality Management Systems?

During this webinar, see how the quality management systems of a life sciences company operate, how a collaborative secure deployment looks like and how it can be adapted to maintaining data integrity in order to deliver drugs to market quicker with the following key benefits:

  • 60% increase in right-first-time submissions
  • 80% reduction in approval times
  • 85% improvement in regulatory compliance
VIEW THE WEBINAR!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to:

Dassault Systèmes Americas